Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Anton A. Chernov"'
Autor:
Daria S. Fomina, Sergey V. Fedosenko, Elena N. Bobrikova, Anton A. Chernov, Olga A. Mukhina, Marina S. Lebedkina, Alexander V. Karaulov, Asel Yu. Nurtazina, Mariana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 95, Iss 7, Pp 568-573 (2023)
Background. Dupilumab, a fully human monoclonal antibody directed against the common -subunit of interleukin (IL)-4 receptors and blocking signaling from both IL-4 and IL-13, may be recommended for the treatment of moderate to severe atopic dermatiti
Externí odkaz:
https://doaj.org/article/65e68e2d00ba4c998efe7da08dfc2317
Autor:
Anna A. Roppelt, Marina S. Lebedkina, Anton A. Chernov, Tatiana S. Kruglova, Olga A. Mukhina, Yulia D. Yukhnovskaya, Farida A. Samedova, Ulyana A. Mаrkina, Gerelma V. Andrenova, Alexander V. Karaulov, Mariana A. Lysenko, Daria S. Fomina
Publikováno v:
Терапевтический архив, Vol 95, Iss 1, Pp 78-84 (2023)
Background. Primary immunodeficiencies (PIDs), now known as inborn errors of immunity, are a group of inherited diseases caused by defects in the genes that control the immune response. Patients with PIDs have risks of developing a severe course and/
Externí odkaz:
https://doaj.org/article/2d43eed5d4bf4eb69941f07a641d44c2
Autor:
Daria S. Fomina, Marina S. Lebedkina, Anna A. Iliukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Sergey S. Andreev, Anton A. Chernov, Inna V. Dolzhikova, Tatyana S. Kruglova, Gerelma V. Andrenova, Amir I. Tukhvatulin, Dmitry V. Shcheblyakov, Alexander V. Karaulov, Maryana A. Lysenko, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Several virus-neutralizing monoclonal antibodies (mAbs) have become new tools in the treatment of the coronavirus disease (COVID-19), but their effectiveness against the rapidly mutating virus is questionable. The present study investigated the effec
Externí odkaz:
https://doaj.org/article/670820e7fe5d4672ba2d2ca795a32834
Autor:
Daria S. Fomina, Marina S. Lebedkina, Anton A. Chernov, Ekaterina A. Nikitina, Olga A. Mukhina, Valeriya I. Mikhaylova
Publikováno v:
Consilium Medicum, Vol 24, Iss 8, Pp 552-557 (2022)
Background. Many factors influence the development of atopic dermatitis (AD): genetic, environmental (including exposure to allergens), skin barrier damage, and activation of the T2-pathway immune response. Patients with AD, including those with seve
Externí odkaz:
https://doaj.org/article/afab8cc27ade4a79bdbfb4f5797a7e4e
Autor:
Ulyana A. Markina, Daria S. Fomina, Marina S. Lebedkina, Tatiana S. Kruglova, Anton A. Chernov, Alena I. Zagrebneva, Zinaida Yu. Mutovina, Alexander V. Karaulov, Ekaterina I. Alexeeva, Mariana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 675-682 (2022)
Background. The use of virus-neutralizing monoclonal antibodies is an effective method of etiotropic therapy for SARS-CoV-2 in patients of high-risk groups of severe COVID-19. Regdanvimab is a single-component monoclonal antibodies immunoglobulin G1,
Externí odkaz:
https://doaj.org/article/1ca7266523cb42cb8962e01de2e8c208
Autor:
Alexey I. Khripun, Andrey V. Starshinin, Yulia O. Antipova, Mariana A. Lysenko, Yulia V. Urozhaeva, Olga F. Gavrilenko, Natalya A. Rusantsova, Andrei A. Tyazhelnikov, Elena Yu. Tikhonovskaya, Natalia V. Okolot, Maria V. Sokolova, Daria S. Fomina, Elena N. Simonova, Tatiana S. Kruglova, Anton A. Chernov, Alena I. Zagrebneva
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 668-674 (2022)
Aim. To study the effect of levilimab or baricitinib in combination with standard therapy (ST) on the incidence of severe viral pneumonia associated with a new coronavirus infection COVID-19. Materials and methods. A multicenter, open-label observ
Externí odkaz:
https://doaj.org/article/6e1e406685f6453fb14793c3ed915970
Autor:
Daria S. Fomina, Olga A. Mukhina, Marina S. Lebedkina, Elena N. Bobrikova, Dmitry O. Sinyavkin, Anton A. Chernov, Valeriya I. Mikhailova
Publikováno v:
Consilium Medicum, Vol 24, Iss 3, Pp 170-176 (2022)
Background. Fungal sensitization (FS) often escapes the attention of clinicians when assessing the spectrum of sensitization in patients with atopic diseases. According to cohort studies is found in 310% of the general population and in 720% of asthm
Externí odkaz:
https://doaj.org/article/b2da650f45a144b7a2ffe748ef663dfc
Autor:
Daria S. Fomina, Olga A. Mukhina, Marina S. Lebedkina, Mirada K. Gadzhieva, Elena N. Bobrikova, Dmitry O. Sinyavkin, Vasiliy V. Parshin, Anton A. Chernov, Andrey S. Belevskiy
Publikováno v:
Терапевтический архив, Vol 94, Iss 3, Pp 413-419 (2022)
Introduction. Guidelines on Biological Therapy for Bronchial Asthma of the European Academy of Allergy and Clinical Immunology (EAACI) identified a number of controversial issues for additional outcome analysis using randomized clinical trials and da
Externí odkaz:
https://doaj.org/article/af3d9eb1ce6446daa7ece9b26896ff20
Autor:
Tatyana S. Kruglova, Darya S. Fomina, Nataliya G. Poteshkina, Nadija F. Frolova, Irina P. Beloglazova, Zinaida Yu. Mutovina, Inna V. Samsonova, Elena A. Kovalevskaja, Alena I. Zagrebneva, Sofya A. Serdotetckova, Anton A. Chernov, Maryana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 93, Iss 11, Pp 1316-1324 (2021)
Aim. To determine the criteria for the optimal use of IL-6 receptor blockers in patients with COVID-19 community-acquired pneumonia based on predictors of adverse outcomes. Materials and methods. The single-center, non-randomized prospective study
Externí odkaz:
https://doaj.org/article/6b1c4220c5664b0daa936e831f62deb9
Autor:
Daria S. Fomina, Sofya A. Serdotetskova, Anton A. Chernov, Marina S. Lebedkina, Asel Iu. Nurtazina, Mirada K. Gadzhieva, Olga A. Mukhina, Elena N. Bobrikova
Publikováno v:
Consilium Medicum, Vol 23, Iss 8, Pp 654-661 (2021)
Atopic dermatitis (AD) is a multifactorial genetically determined immune-mediated skin disease. It is difficult to treat and significantly affects patients quality of life. The development of an integrated approach focusing on atopic multimorbidity,
Externí odkaz:
https://doaj.org/article/bd5de3318c2948c5b8cb6c9f71f48f11